Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 3
2004 5
2005 14
2006 11
2007 4
2008 8
2009 4
2010 5
2011 9
2012 5
2013 8
2014 9
2015 7
2016 9
2017 2
2018 6
2019 9
2020 8
2021 14
2022 21
2023 19
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Effect of DMARDs on the immunogenicity of vaccines.
van Sleen Y, van der Geest KSM, Huckriede ALW, van Baarle D, Brouwer E. van Sleen Y, et al. Among authors: van baarle d. Nat Rev Rheumatol. 2023 Sep;19(9):560-575. doi: 10.1038/s41584-023-00992-8. Epub 2023 Jul 12. Nat Rev Rheumatol. 2023. PMID: 37438402 Review.
The hallmarks of CMV-specific CD8 T-cell differentiation.
van den Berg SPH, Pardieck IN, Lanfermeijer J, Sauce D, Klenerman P, van Baarle D, Arens R. van den Berg SPH, et al. Among authors: van baarle d. Med Microbiol Immunol. 2019 Aug;208(3-4):365-373. doi: 10.1007/s00430-019-00608-7. Epub 2019 Apr 13. Med Microbiol Immunol. 2019. PMID: 30989333 Free PMC article. Review.
Vaccines to Protect Older Adults against Pneumococcal Disease.
van de Garde MDB, Knol MJ, Rots NY, van Baarle D, van Els CACM. van de Garde MDB, et al. Among authors: van baarle d. Interdiscip Top Gerontol Geriatr. 2020;43:113-130. doi: 10.1159/000504490. Epub 2020 Apr 9. Interdiscip Top Gerontol Geriatr. 2020. PMID: 32294656 Review.
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial.
Tan NH, Geers D, Sablerolles RSG, Rietdijk WJR, Goorhuis A, Postma DF, Visser LG, Bogers S, van Dijk LLA, Gommers L, van Leeuwen LPM, Boerma A, Nijhof SH, van Dort KA, Koopmans MPG, Dalm VASH, Lafeber M, Kootstra NA, Huckriede ALW, van Baarle D, Zaeck LM, GeurtsvanKessel CH, de Vries RD, van der Kuy PHM; SWITCH ON Research Group. Tan NH, et al. Among authors: van baarle d. Lancet Infect Dis. 2023 Aug;23(8):901-913. doi: 10.1016/S1473-3099(23)00140-8. Epub 2023 Apr 21. Lancet Infect Dis. 2023. PMID: 37088096 Free PMC article. Clinical Trial.
Frailty is related to serum inflammageing markers: results from the VITAL study.
van Sleen Y, Shetty SA, van der Heiden M, Venema MCA, Gutiérrez-Melo N, Toonen EJM, van Beek J, Buisman AM, van Baarle D, Sauce D. van Sleen Y, et al. Among authors: van baarle d. Immun Ageing. 2023 Nov 27;20(1):68. doi: 10.1186/s12979-023-00391-3. Immun Ageing. 2023. PMID: 38012652 Free PMC article.
A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets.
van de Ven K, Lanfermeijer J, van Dijken H, Muramatsu H, Vilas Boas de Melo C, Lenz S, Peters F, Beattie MB, Lin PJC, Ferreira JA, van den Brand J, van Baarle D, Pardi N, de Jonge J. van de Ven K, et al. Among authors: van baarle d. Sci Adv. 2022 Dec 14;8(50):eadc9937. doi: 10.1126/sciadv.adc9937. Epub 2022 Dec 14. Sci Adv. 2022. PMID: 36516261 Free PMC article.
175 results